Literature DB >> 12489270

Modifiable risk factors for colon cancer.

Edward Giovannucci1.   

Abstract

Although many mechanisms remain unclear, a large body of evidence indicates that several dietary and lifestyle factors are likely to have a major influence on the risk of colon cancer. Physical inactivity, excess body weight, and a central deposition of adiposity are consistent risk factors. Overconsumption of energy is likely to be one of the major contributors to the high rates of colon cancer in Western countries. Beyond their influence on energy balance, the independent role of specific macronutrients remain controversial. Red meat, processed meats, and perhaps refined carbohydrates contribute to risk. Recent evidence indicate that chronic hyperinsulinemia may increase risk of colon cancer. As insulin resistance and subsequent hyperinsulinemia is induced by excess energy intake and some aspects of the Western diet (e.g., saturated fats and refined carbohydrates), insulin may be a focus of factors influencing colon cancer risk. Recent evidence also points to a role of IGF-1, but our understanding of modifiable factors that influence levels of these is poor at present. Of note is that hyperinsulinemia increases free IGF-1 exposure [25]. High alcohol consumption, probably in combination with a diet low in some micronutrients such as folate and methionine, and smoking early in life are likely to increase risk of colon cancer. Recent epidemiologic studies have tended not to support a strong influence of fiber; instead, some micronutrients or phytochemicals in fiber-rich foods may be important. Folate is one such nutrient that has received attention lately and is being studied in randomized intervention trials. Agents with chemopreventive properties, such as aspirin and postmenopausal estrogens, have potential adverse effects so a careful consideration of the risk-benefit ratio is required before general recommendations can be made. Other NSAIDs with a potential for reduced toxicity, such as celecoxib, are currently being evaluated for efficacy and toxicity. The overwhelming evidence indicates that primary prevention of colon cancer is feasible. At least 70% of colon cancers may be preventable by moderate changes in diet and lifestyle [197]. Secondary prevention, through screening by sigmoidoscopy and colonoscopy, is also critically important to prevent mortality from colon cancer; however, many of the diet and lifestyle risk factors for colon cancers are the same for cardiovascular disease and for some other cancers, so focusing on the modifiable risk factors for colon cancer is likely to have many additional benefits beyond this cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12489270     DOI: 10.1016/s0889-8553(02)00057-2

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  93 in total

Review 1.  DFMO: targeted risk reduction therapy for colorectal neoplasia.

Authors:  Christina M Laukaitis; Eugene W Gerner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

2.  Mortality of colorectal cancer in Taiwan, 1971-2010: temporal changes and age-period-cohort analysis.

Authors:  Shih-Yung Su; Jing-Yang Huang; Zhi-Hong Jian; Chien-Chang Ho; Chia-Chi Lung; Yung-Po Liaw
Journal:  Int J Colorectal Dis       Date:  2012-07-08       Impact factor: 2.571

3.  Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study.

Authors:  Ali A Siddiqui; Stuart J Spechler; Sergio Huerta; Serag Dredar; Bertis B Little; Byron Cryer
Journal:  Dig Dis Sci       Date:  2008-04-12       Impact factor: 3.199

4.  Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.

Authors:  Hyunsoon Cho; Angela B Mariotto; Bhupinder S Mann; Carrie N Klabunde; Eric J Feuer
Journal:  Am J Epidemiol       Date:  2013-07-03       Impact factor: 4.897

Review 5.  Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions.

Authors:  Jeffrey A Meyerhardt
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

6.  Association between 6-n-propylthiouracil (PROP) bitterness and colonic neoplasms.

Authors:  Marc D Basson; Linda M Bartoshuk; Susan Z Dichello; Lisa Panzini; James M Weiffenbach; Valerie B Duffy
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

7.  Dietary patterns and colon cancer risk in Whites and African Americans in the North Carolina Colon Cancer Study.

Authors:  Jessie A Satia; Marilyn Tseng; Joseph A Galanko; Christopher Martin; Robert S Sandler
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

8.  Physical activity and male colorectal cancer survival.

Authors:  Jeffrey A Meyerhardt; Edward L Giovannucci; Shuji Ogino; Gregory J Kirkner; Andrew T Chan; Walter Willett; Charles S Fuchs
Journal:  Arch Intern Med       Date:  2009-12-14

Review 9.  Environmental influences on the high mortality from colorectal cancer in African Americans.

Authors:  Sumit Sharma; Stephen J D O'Keefe
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

10.  Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.

Authors:  Akiko Hanyuda; Sun A Kim; Alejandro Martinez-Fernandez; Zhi Rong Qian; Mai Yamauchi; Reiko Nishihara; Teppei Morikawa; Xiaoyun Liao; Kentaro Inamura; Kosuke Mima; Yin Cao; Xuehong Zhang; Kana Wu; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Ramesh A Shivdasani; Shuji Ogino
Journal:  Ann Surg Oncol       Date:  2015-11-17       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.